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Domestic cats develop an asymptomatic, productive infection with a feline immunodeficiency virus (PLV) derived from a naturally infected
cougar (P. concolor). We previously demonstrated that there are extensive G to A substitutions, characteristic of host cytidine deaminase editing,
and positive selection on reverse transcriptase in the PLV genome during this cross-species infection. In this study, we evaluated full-length viral
genomes from each of four cats infected with PLV to determine if viral recombination occurred during this single source infection. Recombination
rates were measurable in three of the four infected cats. In two of these animals, a single site in reverse transcriptase was under positive selection
and there was significant topological incongruence among individual genes in the 3′ half of the genomes. The break point was proximate to a
splice site used for accessory gene expression. Our data indicate that recombination can facilitate lentivirus persistence in unfavorable
environments such as a new host species.
© 2006 Elsevier Inc. All rights reserved.Keywords: Lentivirus; Cross-species infection; Recombination; Evolutionary genetics; Reverse transcriptaseIntroduction
Genetic diversity provides the raw material for adaptation
and survival of all species. RNA viruses are adept at achieving
diversity with spontaneous mutation rates ranging from 10−3 to
10−6 substitutions per site per year due to low polymerase
fidelity and lack of proofreading capacity. In addition to a
remarkable mutation rate, RNAviruses can also create diversity
by recombination (Worobey and Holmes, 1999). In particular,
recombination is a hallmark of lentivirus infections and
contributes significantly to viral diversity both within individual
hosts and within populations (Apetrei et al., 2004; Bachmann et
al., 1997; Chin et al., 2005). The life history strategy of
lentiviruses facilitates recombination because the virus particle⁎ Corresponding author. Fax: +1 406 243 4304.
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doi:10.1016/j.virol.2006.08.026contains two single stranded copies of the viral genome.
Template switching occurs during replication in all lentiviruses,
but the frequency of crossovers and factors promoting
recombination can be variable.
From an evolutionary perspective, viral recombination may
have several advantages. Viruses experience a bottleneck at
every transmission event. The random selection of a small
number of virions to initiate each new infection can lead to the
accumulation of deleterious mutations in the population. The
process by which population fitness declines due to population
bottlenecks has been experimentally determined for several
RNA viruses (Chao, 1990; Chao et al., 1997; Fernandez-
Cuartero et al., 1994). Recently, it has been demonstrated that
deleterious mutations are higher in organisms that replicate
asexually compared to those with sexual strategies (Paland and
Lynch, 2006). Thus recombination is a mechanism for haploid
organisms such as viruses to prevent the accumulation of
147M. Poss et al. / Virology 359 (2007) 146–151deleterious substitutions that have negative impact on popula-
tion fitness.
Recombination can also be advantageous to a virus in a
fluctuating environment because it increases virus genetic
diversity. Arguably, one of the most profound environmental
changes experienced by a virus is replication within a new host
species. We recently described the evolutionary genetics of
FIVpco isolate PLV-1695 (PLV), which was derived from a
naturally infected cougar, during experimental cross-species
infection of domestic cats (Poss et al., 2006). The estimated
evolutionary rates of PLV were an order of magnitude higher
than those determined for FIVpco in the natural host. Most
significantly, we demonstrated that there was extensive
accumulation of errors due principally to G to A substitution
in the PLV genome. The pattern of substitutions suggested that
cytidine deamination of the PLV genome was responsible for
the substitution bias. Despite the accumulation of deleterious
substitutions, the majority of cats experimentally infected with
PLV maintained a low level but persistent viremia. The only
evidence of positive selection on the entire viral genome was at
five sites in reverse transcriptase.
We considered that the rapid accumulation of deleterious
mutations in the viral genome could enhance recombination and
thus contribute to virus persistence in a new host. Detecting
recombinants in single source infections is difficult because a
clear mosaic pattern, which is detectable in recombinants
derived from different genetic subtypes, is not often discernable.
However, measurable recombination has been reported recently
in an individual infected with HIV-1 from a single source
(Shriner et al., 2004). In this report, we evaluate recombination
in four cats experimentally infected from a single source PLV
inoculum and report that there is measurable recombination in
this cross-species infections.Table 1
Summary of recombination and selection estimates on PLV genomes
Cat
ID
Load a C b
5′ e 3′ f
P90 181 1.58E-06 (0.71–2.75E-06) 5.83E-06 (2.76–10
P96 109 ⁎6.75E-11 ⁎1.82E-10
P00 74 4.22E-06 (1.90–7.34E-06) ⁎2.13E-10
P03 140 3.59 E-06 (1.23–8.01E-06) 2.49E-06 (0.37–7.
a Proviral copies per million peripheral blood mononuclear cells.
b Recombinations per site per generation. The mean value and (95% highest post
c Shimodaira-Hasegawa test for topological congruence. The symbol <> indicates
d Site determined to be under positive selection. Significance values are given for bo
2005a) analyses, respectively.
e 5′ half genome fragment (3475bp).
f 3′ half genome fragment (4267bp).
g PRT. Protease and reverse transcriptase portion of pol.
h UI. dUTPase and integrase portion of pol.
i NSD. No significant difference.
j ND. Not done.Results and discussion
The estimated substitution rates for both 5′ and 3′ PLV
genome fragments from all cats were statistically indistinguish-
able and ranged from 1.08–3.61×10−5 substitutions per site per
day. Recombination rates could be measured in both 5′ and 3′
half-genome fragments from two cats (P03 and P90) and the 5′
half-genome segment in P00 only at day 17 post-infection
(Table 1). The rates at other time points and in cat P96 at day 17
could not be estimated because the chains failed to converge.
There was no difference in recombination rate estimates
between the 5′ and 3′ half genomes of P03. However in cat
P90, the recombination rate in the 3′ portion of the genome was
significantly higher than in the 5′ fragment. Because substitu-
tion rates were essentially identical among cats and half-genome
fragments, we conclude that there were no evident affects of
recombination on substitution rates.
The data indicate that there are 0.02 to 0.06 recombination
events per genome per day. The recombination rate obtained by
Shriner et al. (2004) for HIV-1 during in vivo infection was 0.09
recombinations per generation using similar methods and
assuming a neutral mutation rate of 2.5×10−5 per site per
generation (Mansky, 1996). We note that the empirically
determined substitution rates for both 5′ and 3′ genome
fragments of PLV in all cats (1.08–3.61×10−5 substitutions
per site per day) is consistent with the neutral mutation rate of
2.5×10−5 per site per generation used in estimating C in HIV.
Thus the mutation rate is approximately ten-fold higher than the
recombination rate for this FIVpco isolate in a new host, which
is comparable to that measured in HIV-1-infected individuals.
There was significant incongruence between env and UI (the
dUTPase and integrase encoding portion of pol) genes in the
two cats (P90 and P03) in which recombination rates could beSHc Selection d
5′ 3′
.6E-06) gag<>PRTg UI h-vif<>OrfA-env PRT G141
P<0.002
P<0.13
NSD i ND j dUTP G7
P<0.02
P<0.14
NSD NSD none
60E-06) NSD UI-vif<>OrfA-env PRT G141
P<0.02
P<0.12
erior density interval). *Indicates that chains did not converge.
the gene combination that have significantly discordant phylogenies.
th PAML (Bayes Empirical Bayes) (Yang et al., 2005) and FEL (Pond and Frost,
Fig. 1. Maximum likelihood trees based on (A and C) a 1848-bp fragment of PLV spanning dUTPase through vif and (B and D) a 2408 fragment of PLV spanning OrfA
through env. Seven sequences from cat P03 (A and B) and eight sequences from P90 (C and D) derived at day 17 post-inoculation were used for the analysis of
topological congruence of each gene in the 3′ half genome given the sequence data matrix for any one gene using the Shimodaira–Hasegawa test.
148 M. Poss et al. / Virology 359 (2007) 146–151estimated for both half-genome fragments (Fig. 1). To
determine the region of recombination more precisely, we
compared topologies for all combinations of adjacent genes
(e.g., UI-vif or UI-vif-OrfA). There was significant incongru-
ence between segments containing UI-vif and OrfA-env in both
P90 and P03 sequences. The significant differences in topology
were maintained if vif was included with the 3′ OrfA-env
segment and compared to UI. Thus, the recombination break
point appeared to be in UI or the beginning of vif. Of interest,
this region corresponds to the portion of the retroviral genome
that encodes viral accessory genes.
All lentivirus accessory genes are expressed by one or more
splicing events. Splice sites are often associated with substantial
secondary structure. Based on predictive algorithms, the PLV
genome has a major splice donor and a weak splice acceptorFig. 2. Diagram of the relative positions of open reading frames and of predicted splic
predicted using Genie (Reese et al., 1997). The strength of the numerical support valu
no label (90–95). Support for splice acceptors is shown as; SA (95–100), Sa (90–9present near the region of recombination (Fig. 2). This splice
acceptor is used for expression of accessory genes of FIV from
domestic cats, cougars, and Pallas' cats (Tomonaga et al., 1992;
Zou et al., 1997) (Poss; unpublished data). A 200-bp portion of
the sequence (5200–5399 of DQ192583) including the
predicted splice acceptor and donor was submitted to Mfold
(Lyngso et al., 1999) to assess potential secondary structure of
this region. In all predicted structures, the splice acceptor
sequence forms a hairpin stabilized by 16 Watson-Crick base
pairs (Fig. 3).
It is noteworthy that there was positive selection at site G141
only in cats in which recombination rates were estimable in both
5′ and 3′ genome fragments and recombination led to
significant phylogenetic discordance in the 3′ half genome
(P90 and P03). As described in our previous study, five sites,e donor (upright triangles) and acceptor (arrows) sites for PLV. Splice sites were
es for splice donor predictions is indicated as follows; SD (>98), SD (95–97), or
5), SA (80–89) or no label (<79).
Fig. 3. Representative diagram of RNA folding predicted using Mfold (Lyngso et al., 1999). The region evaluated is a 200-bp fragment that includes the predicted
splice acceptor and donor at the end of pol.
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RT (Poss et al., 2006). Selection only at G141 could reflect the
shorter time frame (15–16weeks) of this experiment compared
to the 37-week period evaluated in the previous study. Indeed,
positive selection at site G69 of RT, which was determined to be
under positive selection in the previous study, was also
identified in the PAML analysis of P90 and P03 sequences
but support for selection at this site was not significant (P<0.13
and P<0.34, for P90 and P03 respectively). Thus, substitutions
may occur sequentially in PLV RT during cross-species
infection, much as they do in HIV RT during drug therapy
(Boucher et al., 1992; Iglesias-Ussel et al., 2002).
Typically, measurable recombination indicates that a propor-
tion of cells are infected with more than one virus. During
particle assembly, a representative genome from each of the
coinfecting strains would be packaged and a recombinant virus
would be generated during a subsequent round of infection
because strand switching occurs normally during minus strand
DNA synthesis (Coffin, 1979; Hu and Temin, 1990a, 1990b).
However, it is possible that detectable recombination could also
occur during reverse transcription in a cell infected with a single
virion undergoing editing on both strands of the RNA genome.
Thus, infection of cells by more than one virion may not be the
only means to provide the heterogeneity in the two strands of
the retroviral genome needed to detect recombination.
Our data highlight the significance of recombination to
lentiviral persistence and are relevant to virus survival in new
environments such as a new host or those created by drug
therapy. Driving viruses into “error catastrophe” has been
suggested as a mechanism to eliminate persistent viruses
(Anderson et al., 2004; Castro et al., 2005; Contreras et al.,
2002; Crotty et al., 2001; Domingo et al., 2005; Eigen, 2002;Freistadt et al., 2004; Gonzalez-Lopez et al., 2004). However,
some of the substitutions that arise in HIV-1 RT that confer
resistance to nucleoside inhibitors also enhance recombination
(Nikolenko et al., 2004). It is important to determine if
recombination can restore fitness of virus populations experi-
encing extensive error burdens such as those documented in this
experimental cross-species infection (Poss et al., 2006). If
recombination can be enhanced by point mutations, then
attempts to exceed an error threshold in lentivirus infection
may have highly variable, and potentially untoward, results.
Methods
Sequence preparation
Blood samples were obtained from four cats at 17, 45, 80,
and 115days post-inoculation with PLV. Peripheral blood
mononuclear cells (PBMC) were isolated and proviral loads
were determined by quantitative PCR as described (Terwee et
al., 2005). The coding region of the genome was amplified in
two non-overlapping fragments in replicate PCR using an
estimated template copy number of 1–10 to avoid resampling
the same viral genome (Poss et al., 2006). Each fragment was
cloned and sequenced as previously described (Poss et al.,
2006) and alignments consisting of 7–8 half-genome sequences
for each cat were generated manually.
Evolutionary analyses
Recombination rate analysis was conducted on samples
obtained at each time point. Relative recombination rates (r=
C/mu where C is recombinations per site per day and mu is
150 M. Poss et al. / Virology 359 (2007) 146–151the substitution rate per site per day) were estimated from the
sequence alignments from each cat using Lamarc (Kuhner,
2006; Kuhner et al., 2000). The search strategy consisted of ten
initial and two final Markov chains. Five hundred or 100,000
trees were sampled with sampling increments of 20 and 100 for
initial and final chains, respectively.
Substitution rates were estimated from half-genome sequen-
ces derived from sequential samples using Bayesian inference
and a Markov chain Monte Carlo (MCMC) analysis with
BEAST v1.2 software (Drummond, 2002; Drummond et al.,
2005). Each MCMC chain was run for 108 generations with
parameters sampled every 103 generations. The first 104
samples, representing 107 generations, were discarded as burnin.
The coalescent prior used was the Bayesian Skyline, which
effectively integrates across demographic models and does not
force any functional relationship on effective population size
(Drummond et al., 2005).
Maximum likelihood trees were generated for the half-
genome fragment and each constituent gene based on the
optimized model of evolution determined in Modeltest (Posada
and Crandall, 1998). The Shimodaira–Hasegawa test (Shimo-
daira and Hasegawa, 1999) implemented in Paup⁎ (Swofford,
1999) was used to determine if there was topological
congruence among genes in the viral genome. A null
distribution was generated from 1000 bootstrap replicates of
the test matrix using the full optimization option.
The selection profiles on each gene in the PLV genome
except for rev were determined by two methods. For both, a
maximum likelihood tree was produced for each gene based on
the optimized model of evolution determined in Modeltest
(Posada and Crandall, 1998). The sequence alignment and tree
were submitted to the Hyphy package available from Data-
Monkey (http://www.datamonkey.org) and fixed effects like-
lihood (FEL) methods using the REV (GTR, general time
reversible) model of evolution were used to assess selection
(Pond and Frost, 2005a, 2005b). Codon-based substitution
models available in the CODEML module of PAML (Yang,
1997) (Yang et al., 2005) were considered that allowed different
values for the parameter ω, the ratio of the rates of
nonsynonymous and synonymous substitutions. A likelihood
ratio test with the Bonferroni correction for multiple tests was
used to determine the model that best fit the data and the Bayes
empirical Bayes (BEB) calculation of posterior probabilities for
site classes was used to calculate the probabilities of sites under
positive selection (Yang et al., 2005).
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